Xiangchen Meng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiangchen Meng has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Shuo Yang
6 shared publicationsHang Yu
Key Laboratory of Dairy Science, Ministry of Education, Northeast Agricultural University, Harbin 150030, China
3 shared publicationsQian Su
3 shared publicationsYan Li
3 shared publications- Bofan Duan
Key Laboratory of Dairy Science, Ministry of Education, Northeast Agricultural University, Harbin 150030, China
2 shared publications Huanxin Guo
Key Laboratory of Dairy Science, Ministry of Education, Northeast Agricultural University, Harbin 150030, China
2 shared publications
Latest Publications
- Open Access
- 13 April 2026
- Published by Elsevier in SSRN Electronic Journal
Energy collapse orchestrates phenyllactic acid-induced apoptosis-like death in Mucor racemosus: Antifungal strategy via metabolic disruption
Postharvest rot caused by the phytopathogenic fungus Mucor racemosus leads to significant economic losses in sweet cherry. Phenyllactic acid (PLA), a natural metabolite of lactic acid bacteria, is a highly promising candidate for postharvest decay control. This study elucidates the mode of action of PLA, demonstrating that it induces apoptosis-like death in M. racemosus through acute energy depletion. Following 4 h of treatment, PLA exerted three synergistic attacks on cellular bioenergetics: mitochondrial uncoupling, inhibition of key metabolic enzymes (succinate dehydrogenase (SDH), isocitrate dehydrogenase (IDH), and pyruvate kinase (PK)), and impairment of ATP-dependent ion pumps. These coordinated insults severely depleted ATP levels, which subsequently triggered Ca2+ overload, reactive oxygen species (ROS) accumulation, and progressive mitochondrial dysfunction. The latter was characterized by mitochondrial membrane potential (MMP) collapse, opening of the mitochondrial permeability transition pore (mPTP), and release of cytochrome c into the cytosol. Critically, Ca2+ and ROS formed a self-amplifying feedback loop that perpetuated oxidative damage and drove irreversible mitochondrial collapse, ultimately executing apoptosis-like death. By establishing acute energy depletion as the central hub of this lethal cascade, this work provides mechanistic insights into the antifungal activity of PLA and supports its further development as a biochemical pesticide for postharvest disease management.
- 13 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessEnergy collapse orchestrates phenyllactic acid-induced apoptosis-like death in Mucor racemosus: Antifungal strategy via metabolic disruption
Postharvest rot caused by the phytopathogenic fungus Mucor racemosus leads to significant economic losses in sweet cherry. Phenyllactic acid (PLA), a natural metabolite of lactic acid bacteria, is a highly promising candidate for postharvest decay control. This study elucidates the mode of action of PLA, demonstrating that it induces apoptosis-like death in M. racemosus through acute energy depletion. Following 4 h of treatment, PLA exerted three synergistic attacks on cellular bioenergetics: mitochondrial uncoupling, inhibition of key metabolic enzymes (succinate dehydrogenase (SDH), isocitrate dehydrogenase (IDH), and pyruvate kinase (PK)), and impairment of ATP-dependent ion pumps. These coordinated insults severely depleted ATP levels, which subsequently triggered Ca2+ overload, reactive oxygen species (ROS) accumulation, and progressive mitochondrial dysfunction. The latter was characterized by mitochondrial membrane potential (MMP) collapse, opening of the mitochondrial permeability transition pore (mPTP), and release of cytochrome c into the cytosol. Critically, Ca2+ and ROS formed a self-amplifying feedback loop that perpetuated oxidative damage and drove irreversible mitochondrial collapse, ultimately executing apoptosis-like death. By establishing acute energy depletion as the central hub of this lethal cascade, this work provides mechanistic insights into the antifungal activity of PLA and supports its further development as a biochemical pesticide for postharvest disease management.
- 17 December 2025
- Published by Elsevier in Food Chemistry
- Vol. 502, 147635
From aroma to off-flavor: Metabolomics unveils the metabolic double-sided nature of traditional Chinese fermented foods
- 17 December 2025
- Published by Elsevier in Food Chemistry
- Vol. 502, 147635
From aroma to off-flavor: Metabolomics unveils the metabolic double-sided nature of traditional Chinese fermented foods
- 22 September 2025
- Published by Elsevier in Food Chemistry
- Vol. 495 (Pt 2) , 146350
Lactiplantibacillus plantarum-mediated bioconversion of blue honeysuckle juice amplifies phenolics to inhibit xanthine oxidase and reshapes volatile metabolome
- 22 September 2025
- Published by Elsevier in Food Chemistry
- Vol. 495 (Pt 2) , 146350
Lactiplantibacillus plantarum-mediated bioconversion of blue honeysuckle juice amplifies phenolics to inhibit xanthine oxidase and reshapes volatile metabolome
- Open Access
- 1 September 2025
- Published by Tsinghua University Press in Food Science of Animal Products
- Vol. 3 (3)
Study on improving the quality of fermented goat milk and its mechanism by exopolysaccharide-producing Bifidobacterium breve
The quality of fermented milk can be improved by the exopolysaccharides (EPSs) produced by probiotics. Bifidobacterium breve H4-2 and H9-3 with different EPS production were used as co-fermented probiotics to ferment goat milk in the present study. The physicochemical properties of fermented goat milk and the interaction between goat milk casein and CEPS (EPSs separated from starter culture and B. breve H4-2 fermented goat milk) were investigated. Results indicated that both B. breve H4-2 and H9-3 have similar gene clusters for EPS synthesis, but B. breve H4-2 exhibits a higher ability in EPS productions. Compared to the starter culture group, combining B. breve H4-2 or H9-3 with a starter culture significantly increased the levels of EPSs ((724.16 ± 1.54) and (607.15 ± 4.55) mg/L) and lactic acid ((14.62 ± 0.02) and (16.87 ± 0.01) mg/mL) at the late storage period. Co-fermentation also enhanced the water holding capacity, firmness, consistency, cohesion, and viscosity index, reduced dehydration in fermented goat milk. Moreover, the interaction study revealed that CEPS reduced the particle size and increased the ζ-potential absolute value of the CEPS and casein mixture system. Additionally, CEPS effectively mitigated casein aggregation, thereby enhancing the stability of fermented goat milk. These findings present a novel perspective for the development of a natural starter.
- 1 September 2025
- Published by Tsinghua University Press in Food Science of Animal Products
- Vol. 3 (3)
Open AccessStudy on improving the quality of fermented goat milk and its mechanism by exopolysaccharide-producing Bifidobacterium breve
The quality of fermented milk can be improved by the exopolysaccharides (EPSs) produced by probiotics. Bifidobacterium breve H4-2 and H9-3 with different EPS production were used as co-fermented probiotics to ferment goat milk in the present study. The physicochemical properties of fermented goat milk and the interaction between goat milk casein and CEPS (EPSs separated from starter culture and B. breve H4-2 fermented goat milk) were investigated. Results indicated that both B. breve H4-2 and H9-3 have similar gene clusters for EPS synthesis, but B. breve H4-2 exhibits a higher ability in EPS productions. Compared to the starter culture group, combining B. breve H4-2 or H9-3 with a starter culture significantly increased the levels of EPSs ((724.16 ± 1.54) and (607.15 ± 4.55) mg/L) and lactic acid ((14.62 ± 0.02) and (16.87 ± 0.01) mg/mL) at the late storage period. Co-fermentation also enhanced the water holding capacity, firmness, consistency, cohesion, and viscosity index, reduced dehydration in fermented goat milk. Moreover, the interaction study revealed that CEPS reduced the particle size and increased the ζ-potential absolute value of the CEPS and casein mixture system. Additionally, CEPS effectively mitigated casein aggregation, thereby enhancing the stability of fermented goat milk. These findings present a novel perspective for the development of a natural starter.
- Open Access
Mode of antimicrobial action of plantaricin EvF and the design of activity-enhanced mutants
- Open Access
- 21 November 2024
- Published by Taylor & Francis in Gut Microbes
- Vol. 16 (1) , 2430418
Human milk oligosaccharides combine with Bifidobacterium longum to form the “golden shield” of the infant intestine: metabolic strategies, health effects, and mechanisms of action
Human milk oligosaccharides (HMOs) are the third most important nutrient in human milk and are the gold standard for infant nutrition. Due to the lack of an enzyme system capable of utilizing HMOs in the infant intestine, HMOs cannot be directly utilized. Instead, they function as natural prebiotics, participating in the establishment of the intestinal microbiota as a "bifidus factor." A crucial colonizer of the early intestine is Bifidobacterium longum (B. longum), particularly its subspecies B. longum subsp. infantis, which is the most active consumer of HMOs. However, due to the structural diversity of HMOs and the specificity of B. longum strains, studies on their synergy are limited. An in-depth investigation into the mechanisms of HMO utilization by B. longum is essential for applying both as synbiotics to promote early intestinal development in infants. This review describes the colonization advantages of B. longum in the infant intestinal tract and its metabolic strategies for HMOs. It also summarizes recent studies on the effect and mechanism of B. longum and HMOs in infant intestinal development directly or indirectly through the action of metabolites. In conclusion, further structural analysis of HMOs and a deeper understanding of the interactions between B. longum and HMOs, as well as clinical trials, are necessary to lay the foundation for future practical applications as synbiotics.
- 21 November 2024
- Published by Taylor & Francis in Gut Microbes
- Vol. 16 (1) , 2430418
Open AccessHuman milk oligosaccharides combine with Bifidobacterium longum to form the “golden shield” of the infant intestine: metabolic strategies, health effects, and mechanisms of action
Human milk oligosaccharides (HMOs) are the third most important nutrient in human milk and are the gold standard for infant nutrition. Due to the lack of an enzyme system capable of utilizing HMOs in the infant intestine, HMOs cannot be directly utilized. Instead, they function as natural prebiotics, participating in the establishment of the intestinal microbiota as a "bifidus factor." A crucial colonizer of the early intestine is Bifidobacterium longum (B. longum), particularly its subspecies B. longum subsp. infantis, which is the most active consumer of HMOs. However, due to the structural diversity of HMOs and the specificity of B. longum strains, studies on their synergy are limited. An in-depth investigation into the mechanisms of HMO utilization by B. longum is essential for applying both as synbiotics to promote early intestinal development in infants. This review describes the colonization advantages of B. longum in the infant intestinal tract and its metabolic strategies for HMOs. It also summarizes recent studies on the effect and mechanism of B. longum and HMOs in infant intestinal development directly or indirectly through the action of metabolites. In conclusion, further structural analysis of HMOs and a deeper understanding of the interactions between B. longum and HMOs, as well as clinical trials, are necessary to lay the foundation for future practical applications as synbiotics.
- Open Access
A New Combination of Bifidobacterium bifidum and Lactococcus lactis Strains with Synergistic Effects Alleviates Colitis-Associated Colorectal Cancer
Chronic inflammation is a factor in the development of cancer, and probiotics play a role in preventing or treating inflammation as an adjuvant therapy. To investigate potential probiotics for the prevention of colitis-associated colorectal cancer (CAC), Bifidobacterium bifidum H3-R2 and Lactococcus lactis KLDS4.0325 were used to examine the effects on colon cancer cells and in an inflammation-related cancer animal model. The results revealed that B. bifidum H3-R2 in combination with L. lactis KLDS4.0325 caused apoptosis in colon cancer cells by increasing caspase-3 and caspase-9 protein levels, enhancing Bax expression, and lowering Bcl-2 expression. In addition, the combination of the two strains relieved the tissue damage; reduced proinflammatory cytokines, myeloperoxidase (MPO) activity, and hypoxia-inducible factor 1-alpha (HIF-1α) level; upregulated anti-inflammatory cytokines; increased colonic tight junction protein expression; regulated intestinal homeostasis by inhibiting NLRP3 inflammasome signaling pathway; and improved the imbalance of gut microbiota in animal models. Moreover, the combination of the two strains had a greater preventive impact than each strain alone. These findings are supportive of clinical studies and product development of multi-strain probiotic preparations for diseases associated with colitis.
Open AccessA New Combination of Bifidobacterium bifidum and Lactococcus lactis Strains with Synergistic Effects Alleviates Colitis-Associated Colorectal Cancer
Chronic inflammation is a factor in the development of cancer, and probiotics play a role in preventing or treating inflammation as an adjuvant therapy. To investigate potential probiotics for the prevention of colitis-associated colorectal cancer (CAC), Bifidobacterium bifidum H3-R2 and Lactococcus lactis KLDS4.0325 were used to examine the effects on colon cancer cells and in an inflammation-related cancer animal model. The results revealed that B. bifidum H3-R2 in combination with L. lactis KLDS4.0325 caused apoptosis in colon cancer cells by increasing caspase-3 and caspase-9 protein levels, enhancing Bax expression, and lowering Bcl-2 expression. In addition, the combination of the two strains relieved the tissue damage; reduced proinflammatory cytokines, myeloperoxidase (MPO) activity, and hypoxia-inducible factor 1-alpha (HIF-1α) level; upregulated anti-inflammatory cytokines; increased colonic tight junction protein expression; regulated intestinal homeostasis by inhibiting NLRP3 inflammasome signaling pathway; and improved the imbalance of gut microbiota in animal models. Moreover, the combination of the two strains had a greater preventive impact than each strain alone. These findings are supportive of clinical studies and product development of multi-strain probiotic preparations for diseases associated with colitis.